MAUDE Adverse Event Report: RESPIRONICS INC BIPAP AVAPS C SERIES , CHINA, FLOW GEN; VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING

Model Number	1167P
Medical Device Problem Code	Degraded (1153)
Health Effect - Clinical Code	Pulmonary Emphysema (1832)
Date of Event	09/14/2021
Type of Reportable Event	Death
Event or Problem Description
The manufacturer received information alleging a continuous positive airway pressure (cpap) device's sound abatement foam became degraded and caused the patient to develop fungal infection.The patient has reportedly hospitalized in response to the event and has since died.This issue was reported to the fda per 21 cfr 806.The device will be corrected per res 88058.

• Brand Name: BIPAP AVAPS C SERIES , CHINA, FLOW GEN
• Common Device Name: VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING
• Manufacturer (Section D): RESPIRONICS INC; 1001 murry ridge lane; murrysville PA 15568
• MDR Report Key: 12485060
• Report Number: 2518422-2021-04061
• Device Sequence Number: 19791904
• Product Code: MNS
• UDI-Device Identifier: 00606959039261
• UDI-Public: 00606959039261
• Combination Product (Y/N): N
• Initial Reporter Country: CH
• PMA/510(K) Number: K102465
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: distributor,foreign
• Initial Reporter Occupation: Non-Healthcare Professional
• Remedial Action: Recall
• Type of Report: Initial
• Report Date (Section B): 09/16/2021

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Lay User/Patient
• Device Model Number: 1167P
• Device Catalogue Number: 1167P
• Was Device Available for Evaluation?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 09/14/2021
• Initial Report FDA Received Date: 09/16/2021
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: RES 88058
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Death; Hospitalization